Cardiac autophagy is a maladaptive response to hemodynamic stress

Journal of Clinical Investigation

Volumn 117, Issue 7, 2007, Pages 1782-1793

  Zhu, Hongxin ^a   Tannous, Paul ^a   Johnstone, Janet L ^a   Kong, Yongli ^a   Shelton, John M ^a   Richardson, James A ^a,b   Le, Vien ^a   Levine, Beth ^a   Rothermel, Beverly A ^a   Hill, Joseph A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN1; CATHEPSIN D; HEART ANTIBODY; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RISK; CELL DEATH; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HEMODYNAMIC STRESS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADAPTATION, BIOLOGICAL; ANIMAL FEED; ANIMALS; AORTA; AUTOPHAGY; BIOLOGICAL MARKERS; CELL LINE; HEART DISEASES; HETEROZYGOTE; LYSOSOMES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCARDIUM; PROTEINS; RATS;

EID: 34447133404     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27523     Document Type: Article

References (50)

1. Rosamond, W., et al. 2007. Heart disease and stroke statistics - 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 115:e69-e171. doi:10.1161/circulationaha.105.171600.
2. Frey, N., Katus, H.A., Olson, E.N., and Hill, J.A. 2004. Hypertrophy of the heart: a new therapeutic target? Circulation. 109:1580-1589.
3. Heineke, J., and Molkentin, J.D. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7:589-600.
4. Klionsky, D.J., and Emr, S.D. 2000. Autophagy as a regulated pathway of cellular degradation. Science. 290:1717-1721.
5. Levine, B., and Klionsky, D.J. 2004. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell. 6:463-477.
6. Mizushima, N. 2005. The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ. 12(Suppl. 2):1535-1541.
7. Lum, J.J., DeBerardinis, R.J., and Thompson, C.B. 2005. Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 6:439-448.
8. Larsen, K.E., and Sulzer, D. 2002. Autophagy in neurons: a review. Histol. Histopathol. 17:897-908.
9. Hara, T., et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 441:885-889.
10. Komatsu, M., et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 441:880-884.
11. Yue, Z., Jin, S., Yang, C., Levine, A.J., and Heintz, N. 2003. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 100:15077-15082.
12. Qu, X., et al. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112:1809-1820. doi:10.1172/JCI200320039.
13. Gutierrez, M.G., et al. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 119:753-766.
14. Kabeya, Y., et al. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728.
15. Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., and Ohsumi, Y. 2004. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell. 15:1101-1111.
16. Berenji, K., Drazner, M.H., Rothermel, B.A., and Hill, J.A. 2005. Does load-induced ventricular hypertrophy progress to systolic heart failure? Am. J. Physiol. Heart Circ. Physiol. 289:H8-H16.
17. Rothermel, B.A., et al. 2005. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol. Genomics. 23:18-27.
18. Hill, J.A., et al. 2000. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation. 101:2863-2869.
19. Pattingre, S., et al. 2005. Bcl-2 antiapoptotic proteins inhibit beclin-1-dependent autophagy. Cell. 122:927-933.
20. Kuma, A., et al. 2004. The role of autophagy during the early neonatal starvation period. Nature. 432:1032-1036.
21. Kihara, A., Noda, T., Ishihara, N., and Ohsumi, Y. 2001. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152:519-530.
22. Yousefi, S., et al. 2006. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 8:1124-1132.
23. Kang, P.M., and Izumo, S. 2000. Apoptosis and heart failure - a critical review of the literature. Circ. Res. 86:1107-1113.
24. Narula, J., Kolodgie, F.D., and Virmani, R. 2000. Apoptosis and cardiomyopathy. Curr. Opin. Cardiol. 15:183-188.
25. Gonzalez, A., et al. 2003. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc. Res. 59:549-562.
26. Wencker, D., et al. 2003. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111:1497-1504. doi:10.1172/JCI200317664.
27. Shintani, T., and Klionsky, D.J. 2004. Autophagy in health and disease: a double-edged sword. Science. 306:990-995.
28. Yu, L., et al. 2006. Autophagic programmed cell death by selective catalase degradation. Proc. Natl. Acad. Sci. U. S. A. 103:4952-4957.
29. Liang, X.H., et al. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 402:672-676.
30. Decker, R.S., Decker, M.L., Herring, G.H., Morton, P.C., and Wildenthal, K. 1980. Lysosomal vacuolar apparatus of cardiac myocytes in heart of starved and refed rabbits. J. Mol. Cell. Cardiol. 12:1175-1189.
31. Yamamoto, S., Sawada, K., Shimomura, H., Kawamura, K., and James, T.N. 2000. On the nature of cell death during remodeling of hypertrophied human myocardium. J. Mol. Cell. Cardiol. 32:161-175.
32. Lockshin, R.A., and Zakeri, Z. 2002. Caspase-independent cell deaths. Curr. Opin. Cell Biol. 14:727-733.
33. Yan, L., et al. 2005. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 102:13807-13812.
34. Akazawa, H., et al. 2004. Diphtheria toxin-induced autophagic cardiomyocyte death plays a pathogenic role in mouse model of heart failure. J. Biol. Chem. 279:41095-41103.
35. Hamacher-Brady, A., Brady, N.R., and Gottlieb, R.A. 2006. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281:29776-29787.
36. Matsui, Y., et al. 2007. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100:914-922.
37. Pfeifer, U., Fohr, J., Wilhelm, W., and Dammrich, J. 1987. Short-term inhibition of cardiac cellular autophagy by isoproterenol. J. Mol. Cell. Cardiol. 19:1179-1184.
38. Pfeifer, U., and Dammrich, J. 1986. Intracellular turnover and cardiac hypertrophy. Basic Res. Cardiol. 81(Suppl. 1):139-146.
39. Tanaka, Y., et al. 2000. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature. 406:902-906.
40. Choudhury, L., et al. 2002. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 40:2156-2164.
41. Wang, T.J., et al. 2003. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 108:977-982.
42. Dong, X., et al. 2004. In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 287:H1417-H1425.
43. Sawyer, D.B., et al. 2002. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34:379-388.
44. Rodriguez-Enriquez, S., He, L., and Lemasters, J.J. 2004. Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int. J. Biochem. Cell Biol. 36:2463-2472.
45. Tian, R., Musi, N., D'Agostino, J., Hirshman, M.F., and Goodyear, L.J. 2001. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation. 104:1664-1669.
46. Liang, J., et al. 2007. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 9:218-224.
47. Rockman, H.A., et al. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 88:8277-8281.
48. Hill, J.A., et al. 2002. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. J. Biol. Chem. 277:10251-10255.
49. Kong, Y., et al. 2006. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation. 113:2579-2588.
50. Schiller, N.B., et al. 1979. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation. 60:547-555.